Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07611357 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

[18F]F-AraG PET Imaging in Alzheimer's Disease

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study evaluates the use of \[18F\]F-AraG PET/CT imaging to quantify activated T cell involvement in patients with Alzheimer's disease (AD). Participants will undergo total-body dynamic PET imaging to assess tracer uptake in the brain and peripheral organs. Results will be compared between participants with AD and healthy controls to characterize both central nervous system and systemic immune alterations in AD
Trial Details
NCT Number NCT07611357
Lead Sponsor CellSight Technologies, Inc.
Collaborators: University of California, Davis
Conditions
(from sponsor)		 Alzheimer Disease (AD)
Related terms Alzheimer Disease
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov